Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis.
Animals
Bacterial Proteins
/ metabolism
Carbapenem-Resistant Enterobacteriaceae
/ drug effects
Colistin
/ therapeutic use
Disease Models, Animal
Drug Resistance, Multiple, Bacterial
Drug Therapy, Combination
Drugs, Generic
/ pharmacokinetics
Klebsiella Infections
/ drug therapy
Klebsiella pneumoniae
/ drug effects
Meropenem
/ blood
Microbial Sensitivity Tests
Osteomyelitis
/ drug therapy
Rabbits
Therapeutic Equivalency
beta-Lactamases
/ metabolism
Carbapenemase
Colistin
Generics
Klebsiella pneumoniae
Meropenem
Osteomyelitis
Journal
International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
05
01
2020
revised:
06
08
2020
accepted:
29
08
2020
pubmed:
9
9
2020
medline:
7
7
2021
entrez:
8
9
2020
Statut:
ppublish
Résumé
Guidelines for the management of carbapenemase-producing Enterobacterales (CPE) infections recommend a combination of two active agents, including meropenem if the minimum inhibitory concentration (MIC) is ≤8 mg/L. The therapeutic equivalence of meropenem generics has been challenged. We compared the bactericidal activity of meropenem innovator (AstraZeneca) and four generic products (Actavis, Kabi, Mylan and Panpharma), both in vitro and in vivo, in association with colistin. In vitro time-kill studies were performed at 4 × MIC. An experimental model of KPC-producing Klebsiella pneumoniae osteomyelitis was induced in rabbits by tibial injection of a sclerosing agent followed by 2 × 10
Identifiants
pubmed: 32898684
pii: S0924-8579(20)30351-4
doi: 10.1016/j.ijantimicag.2020.106152
pii:
doi:
Substances chimiques
Bacterial Proteins
0
Drugs, Generic
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Meropenem
FV9J3JU8B1
Colistin
Z67X93HJG1
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106152Informations de copyright
Copyright © 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.